Upcoming DIA Events in Europe, India, Japan and China

From DIA

China   Training Course: Risk-based Manufacture of Pharmaceuticals: Toxicology and Critical Thinking March 9 | Beijing, China Find out how to better manage risk in the manufacture of pharmaceutical products. This one day session will show you how to use risk assessment for decision-making and also for setting health-based limits. Case studies and examples from a wide variety of fields will be used. There will also be a discussion on effective risk communication.   Europe   25th Annual EuroMeeting March 4-6 | Amsterdam, The Netherlands More than 3,000 professionals involved in the development of medicines from more than 50 countries will gather in Amsterdam at EuroMeeting 2013. The event will feature more than 110 sessions, 200 exhibitors and speakers from the European Medicines Agency, the European Commission, the Food and Drug Administration and other regulatory agencies from around the world.   India   4th Pharmacovigilance Conference in India March 8-9 | Bangalore, India Gain useful new insights into the latest global challenges in drug safety, learn about current global safety reporting requirements for prescription and over-the-counter drugs and discuss new, pragmatic approaches to pharmacovigilance. Other key topics will include the regulatory agency clinical safety and pharmacovigilance inspection program in the US, Europe, and Japan, and identifying best practices for quality assurance in post-marketing pharmacovigilance and clinical safety.   6th Regulatory Conference in India April 5-6 | Ahmedabad, Gujarat, India Remaining competitive in the world market despite ever-evolving regulation is the hot topic at the 6th Regulatory Conference in India. The two-day event, entitled ‘India, the Upcoming Economy: Encouraging Enforcement of Regulations’, will bring together the region’s best talent in the pharmaceutical world to understand what the challenges are and how to face them.   Japan   2nd Project Management Training Course in Japan February 20-21 | Tokyo, Japan A fundamental project management training course on pharmaceutical development. Participants will learn essential and logical techniques of communication, risk management and project team management.   3rd Labeling Workshop in Japan March 16 | Tokyo, Japan How do patients respond to medicine labels? Could the safety messages be clearer? Find out through real examples and prescribers’ views at the 3rd Labeling Workshop. The session will also share information on the experiences of pharmaceutical companies, medical institutes and pharmacists. Submit your abstract for Cardiac Safety Workshop   Call for Abstracts 4th Cardiac Safety Workshop in Japan July 11-12, 2013 | Ivy Hall, Tokyo To submit an abstract for the DIA Cardiac Safety Conference please go to the DIA website: Submission Deadline: February 28, 2013 | Author Notification: March 31, 2013.

Don’t Miss the 5th DIA China Annual Meeting The Preliminary Program for the 5th DIA China 2013 Annual Meeting is now available and registration is open. Find the key themes and sessions at this year's event and register early! Register Now View the Preliminary Program PROGRAM CO-CHAIRPERSONS Lingshi TAN, PhD General Manager, Pfizer (China) R&D Co., Ltd. Vice President, Pfizer Worldwide Development Operations, China Yajun ZHAO Director-General, China Center for Pharmaceutical International Exchange(CCPIE), China PROGRAM VICE CHAIRPERSON Dayao ZHAO, MD, PhD Vice President, Janssen Pharmaceutical Research & Development Head of China Research & Development and Scientific Affairs ANNUAL MEETING THEME SNAPSHOT Chemistry, Manufacturing and Controls (CMC) /cGMP Clinical Research and Operations Data Management Drug Safety and Pharmacovigilance Regulatory Science Statistics The Pathway to Success for CROs and SMOs in China Vaccines and Biologics New Programs: SFDA Town Hall Meeting Regulatory and Drug Safety Joint Session: Balancing Risk and Benefit during NDA and Post Marketing Periods Botanical Drug Products in China and the United States Future Oncology Drug Development: Opportunities and Challenges Innovation on Medical Devices and Combinational Products Pharmacoepidemiology – Best Practices and Drug Safety Pharm/Tox Post Approval Studies Development of Novel Traditional Chinese Medicines (TCMs) PRECONFERENCE WORKSHOPS Maximize your learning while attending the 5th DIA China Annual Meeting! Pre-conference workshops include: Analysis of Data Patterns to Monitor and Assess Outcomes of Clinical Studies Drug Substance and Drug Products Stability Requirements and Practice in Early Phase Development Data Management for Oncology Trials Applying MedDRA with Clinical Safety and Pharmacovigilance Practices: Regulatory Perspective Global Clinical Trials - Principles and Case Studies LESS THAN TWO MONTHS LEFT TO SUBMIT YOUR RESEARCH Call for Abstracts Deadline: Monday, February 25 Call for Posters Deadline: Monday, March 25 Click here for information about submission of Abstracts/Posters. CHINA ANNUAL MEETING CONTACTS: China Office: dia@diachina.org XIE Fei: fei.xie@diachina.org HU Rui: rae.hu@diachina.org Tel: +86-10-6260-2240 Fax: +86-10-6260-2201

Email Preferences | My DIA | Forward to a Friend |

Patient Safety: A Sustained Focus from Scientific Ideas to Innovative Medicines - 5th DIA China Annual Meeting - May 12-15, 2013 - Beijing

Hot Topics and Sessions at 5th DIA China 2013 Annual Meeting This year’s theme “Patient Safety: A Sustained Focus from Scientific Ideas to Innovative Medicines”  will reinforce patient safety as a core element of therapeutic innovation and a key philosophy throughout the life cycle of biopharmaceutical R&D. 5th DIA China 2013 Annual Meeting will be held on May 12-15, 2013 at the Beijing International Convention Center in Beijing. It is expected to attract over 1200 professional participants, spotlighted with plenary and parallel sessions, including pre-conference workshops, forums, speakers and presentations, panel discussions, call for abstracts & posters, exhibitions, networking receptions, and more. 5th DIA China 2013 Annual Meeting is the largest annual meeting held by DIA in Asia & Pacific region, providing a neutral platform for information exchange, featuring speakers that include high-level representatives from government, industry and academics in China and abroad. In 2012, the 4th DIA China Annual Meeting attracted over 1170 participants from all sectors, including multi-national pharma, local pharma, CRO, bio-pharma, regulatory agencies, academic institutes, and clinical sites. NEW subject matter and hot topics include: China drug safety monitoring system and update Medical devices and combinational drugs Oncology drug research - demands and challenges Over the counter drug development in China Pharmacoepidemiology Risk benefits Traditional Chinese Medicines - regulations and patient benefits Don’t miss the region’s biggest meeting for pharmaceutical and medical product professionals to seek the most-up-to-date information and innovative tools you need to get ahead, especially within patients and their safety. DIA China cordially invites you to join us for the 5th DIA China 2013 Annual Meeting! Co-Sponsored By:  China Center for Pharmaceutical International Exchange (CCPIE) CONTACT INFORMATION Conference: Runshan CHEN: ting.chen@diachina.org Fei XIE: fei.xie@diachina.org Tel: +86.10.6260.2240 Exhibtion, advertisement, hosting: Jean XU: jxu@kellencompany.com Tel: +86.10.5923.1096 Sofie PEETERS: speeters@kellencompany.com Tel: +86.159.1093.4696 DIA中国办公室 (DIA CHINA OFFICE) 中国北京海淀区中关村西区海淀东三街2号，欧美汇大厦七层766室，邮编100080 7/F, Room 766, Metropolis Tower, No.2 Haidian East Third Street, Zhongguancun Xi Zone, Haidian District, Beijing, 100080, China Tel: +86.10.6260.2240         Fax: +86.10.6260.2201 Email: dia@diachina.org        Web: www.diachina.org